First-ever mRNA vaccine halts pancreatic cancer in its tracks
50
votes
-
-
Scientists research man missing 90% of his brain who leads a normal life
27 votes -
Scientists find humans age dramatically in two bursts – at 44, then 60
32 votes -
New antiviral HIV drug with 100% prevention efficiency in African women gets prolonged standing ovation at scientific conference
45 votes -
Maglev titanium heart now whirs inside the chest of a live patient
24 votes -
Why don’t we know how antidepressants work yet?
30 votes -
Ozempic and Wegovy linked to rare blindness risk, study finds
27 votes -
Texas abortion ban linked to 13% increase in infant and newborn deaths
54 votes -
Gilead shot prevents all HIV cases in trial of African women
29 votes -
Male birth control gel (that is applied to the shoulders) is safe and effective, new trial findings show
72 votes -
Better depression relief with electromagnetic treatment
8 votes -
Wild Orangutan observed using first aid on a wound
28 votes -
mRNA cancer vaccine reprograms immune system to tackle glioblastoma
12 votes -
AI traces mysterious metastatic cancers to their source
4 votes -
AI assists clinicians in responding to patient messages at Stanford Medicine
4 votes -
German man deliberately receives 217 Covid vaccinations over twenty-nine months, with no adverse events or strong effect on immune system
45 votes -
Progress deferred: Lessons from mRNA vaccine development
9 votes -
AstraZeneca unveils successes in treatment of lung cancer – best-selling Tagrisso drug slows progression of most common form of the disease at an early stage
22 votes -
Researchers find response to ketamine depends on opioid pathways, but varies by sex
10 votes -
Research samples collected over decades at Swedish medical university Karolinska Institutet were destroyed when a freezer malfunctioned during the Christmas holidays
30 votes -
Science sleuths are using technology to find fakery and plagiarism in published research
16 votes -
Scientists use transcranial magnetic stimulation to make patients with chronic pain more hypnotizable
11 votes -
World's first "self-amplifying" vaccine approved in Japan
15 votes -
Wasabi linked to ‘substantial’ memory boost
28 votes -
The business of bad medicine
4 votes -
What am I thankful for this year? Amazing scientific discoveries.
19 votes -
The story of when washing hands was considered crazy
12 votes -
Denmark is building on the success of blockbuster drugs – the country's focus on reinvestment is feeding a stream of discovery
7 votes -
'Not of faculty quality': How Penn mistreated Katalin Karikó, the Nobel Prize winner of 2023
25 votes -
Future technology: Twenty-two ideas about to change our world
6 votes -
Womb transplants are now a life-changing reality. Here’s how the extraordinary procedure works.
37 votes -
Attosecond lasers explained (2023 Nobel Prize in physics)
6 votes -
Rare 1885 photo captures the first licensed women doctors of India, Japan, and Syria
9 votes -
New vaccine technology could protect from future viruses and variants
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants of SARS-CoV-2 – the virus that causes...
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants of SARS-CoV-2 – the virus that causes COVID-19 – as well as other major coronaviruses, including those that caused the first SARS epidemic in 2002.
The studies in mice, rabbits and guinea pigs [...] found that the vaccine candidate provided a strong immune response against a range of coronaviruses by targeting the parts of the virus that are required for replication.
Professor Jonathan Heeney from Cambridge’s Department of Veterinary Medicine, who led the research, [said] “We wanted to come up with a vaccine that wouldn’t only protect against SARS-CoV-2, but all its relatives.”
18 votes -
Anti-COVID drug may have led to virus mutations: study
10 votes -
Recent neuroscience research suggests that popular strategies to control dopamine are based on an overly narrow view of how it functions
17 votes -
Human trials of artificial wombs could start soon. Here’s what you need to know
11 votes -
Will it slip or will it grip: Scientists ask, “what is snail mucus?”
12 votes -
Researchers engineer bacteria that can detect tumor DNA (in mice)
6 votes -
Man bitten by stray cat contracts infection unknown to science
63 votes -
Artificial intelligence versus human-controlled doctor in virtual reality simulation for sepsis team training: Randomized controlled study
10 votes -
New study finds Covid can infect the liver
13 votes -
New tinnitus therapy can quiet torturous ringing in the ears
86 votes -
Golden age of medicine
18 votes -
Trace amounts of antidepressants cause behavioral changes in crayfish, potentially making them more vulnerable to predators
14 votes -
This week in virology 1018: Clinical update
7 votes -
Pacemakers, other implants, made of jelly
3 votes -
Cambridge-Caltech team of scientists claim to have created synthetic human embryos from stem cells at conference; work not yet published
29 votes -
Alzheimer’s drug gets FDA panel’s backing, setting the stage for broader US use
13 votes -
How Sweden and Denmark became rare bright spots for Europe's pharma industry
3 votes